Our products includes HIO-201 PDF and VCE;
We offer HIPAA HIO-201 PDF Dumps containing actual HIO-201 exam questions and answers. These PDF Exam Dumps are very useful in passing the HIO-201 exams with high marks. It is money back guarantee by killexams.com
These HIO-201 questions and answers are in PDF files, are taken from the actual HIO-201 question pool that candidate face in actual test. These real HIPAA HIO-201 exam QAs are exact copy of the HIO-201 questions and answers you face in the exam.
HIO-201 Practice Test uses the same questions and answers that are provided in the actual HIO-201 exam pool so that candidate can be prepared for real test environment. These HIO-201 practice tests are very helpful in practicing the HIO-201 exam.
HIO-201 PDF Dumps are updated on regular basis to reflect the latest changes in the HIO-201 exam. Whenever any change is made in actual HIO-201 test, we provide the changes in our HIO-201 PDF Dumps.
Here you can find complete HIPAA exam collection where PDF Dumps are updated on regular basis to reflect the latest changes in the HIO-201 exam. All the sets of HIO-201 PDF Dumps are completely verified and up to date.
Killexams.com HIO-201 PDF exam dumps contain complete question pool, updated in August 2022 including VCE exam simulator that will help you get high marks in the exam. All these HIO-201 exam questions are verified by killexams certified professionals and backed by 100% money back guarantee.
TOLEDO, Ohio , Aug. 4, 2022 /PRNewswire/ -- Digital 55, a technology development firm based in Toledo, Ohio is preparing to launch the beta test for Inugo Lab, a data record management platform aimed at assisting in professional record storage and compliance tracking, specifically for construction companies, trade unions, and professional industries.
Inugo Lab is a centralized hub for storing and maintaining critical professional records, including those for industry certifications, job eligibility, and safety skills. The system also provides reports and notifications for employee updates to certifications or continuing education, allowing companies to have a real-time evaluation of their current and upcoming recertification needs.
Capable of containing safety records like OSHAA, safety, and certification testing records, Inugo Lab uses state-of-the-art, HIPAA-compliant software and data storage, ensuring your record data is always secure. It can be customized to your program's needs and allows for easy access and updating. The program also provides real-time updating and reporting, keeping both HR and employees up to date on upcoming certification needs at their fingertips.
"Inugo Lab represents the next phase of recording storage and maintenance for small and medium-sized businesses. We've brought together a robust system of tools and resources on an easily customizable platform. These tools are being used by much larger companies but haven't been made available on a scale or price point that SMBs can participate. That changes with Inugo Lab." said Digital 55 CEO Greg Whitlow.
Inugo Lab allows companies to facilitate lab work or safety training through its easy-to-use employee portal. Employees have access to their own records so they can find all the information needed for certification in one place and be proactive about recertification. The system also provides a time-stamped digital certificate for record-keeping, an important tracking tool for both internal use and historical insurance for an employee.
Inugo Lab is the ideal platform for construction and manufacturing companies, professional driving services, trade unions, and related organizations. By providing those companies with an easy-to-use, real-time updated platform, they can Excellerate participation, identify recertification needs, and ensure the safety compliance of their workforce.
The program is expected to be available for beta testing in the 4th quarter of 2022, with a full product launch slated for the 1st quarter of 2023. For more information about Inugo Lab, or to add your name to the beta testing waitlist, please contact Digital 55 at firstname.lastname@example.org or visit our website at https://digital-55.com.
View original content to obtain multimedia:https://www.prnewswire.com/news-releases/digital-55-beginning-beta-testing-of-professional-record-storage-and-compliance-product-301600469.html
SOURCE Digital 55
Jeffrey E. Harris, a primary care physician with Eisner Health in Los Angeles, Calif., and professor of economics emeritus at the Massachusetts Institute of Technology in Cambridge, Mass discusses reproductive privacy rights and the recent Dobbs Supreme Court decision…
The 1996 federal law that protects the privacy of our medical records –the Health Insurance Portability and Accountability Act or HIPAA – has from the outset contained a carefully crafted exception for personal health information that might bear directly on the commission of a crime. But with the overturning of Roe v. Wade and the anticipated criminalization of abortion in about half the United States, this narrow legal conduit will balloon into a multilane channel expansive enough to accommodate a flotilla of aggressive state prosecutors.
Just days after the Supreme Court’s fateful decision in Dobbs, the Office of Civil Rights (OCR) of the U.S. Department of Health and Human Services – the agency that enforces HIPAA’s privacy rule – issued a Guidance intended to blunt the impact of the Court’s ruling. But this nonbinding Guidance will at most wrap a thin gauze over the outer edges of a gaping legal wound. In the real world of the daily practice of medicine, the undoing of Roe will signal not only the demise of a woman’s right to abortion, but also the cancellation of her broader right to reproductive privacy.
Anti-Abortion Legislatures Will Enact Strict Reporting Requirements
The OCR Guidance offers the example of a woman who seeks care in a hospital emergency department (ED) for complications of a miscarriage during the tenth week of pregnancy in a state that prohibits abortions after six weeks. If ED personnel suspect that the woman has taken abortifacient medication and thus broken the law, the hospital may report the event without her permission. Still, the Guidance admonishes, the hospital would be required to do so only if state law mandated such reporting. But anti-abortion state legislatures, intent on counteracting the surge in demand for abortion pills triggered by the shutdown of abortion clinics, will have every incentive to enact strict reporting requirements.
Healthcare Providers and Health Plans Will Have to Comply with Warrants and Subpoenas
The OCR Guidance offers another example of a court order requiring a reproductive health clinic to produce the records of a patient who has had an abortion. The Guidance recognizes that under the HIPAA privacy rule, healthcare providers and health plans are permitted to disclose protected health information to law enforcement officials in order to comply with a court-ordered warrant or subpoena. The Guidance notes, however, that the privacy rule addresses only the conditions under which providers and plans are permitted to comply with warrants and subpoenas, but it does not say whether they are required to comply.
Perhaps large medical centers and insurers will have the legal and financial resources to individually file motions to quash hundreds of subpoenas seeking medical records on women who were documented as pregnant but had no public record of a subsequent birth. But the overwhelming majority of healthcare practices, hospitals, rehab centers, clinics, laboratories, pharmacies, and medical suppliers will simply not be able to resist the efforts of a determined state prosecutor or, in the case of a state that adopts an anti-abortion bounty law, an aggressive private litigator.
It’s All About a Woman’s Reproductive Life, Not Just About Abortion
Lawyers have already begun to advise their clients on ways to shield some types of abortion-related information from prosecutors. With the issue of out-of-state travel to obtain an abortion in mind, one advisor suggested that plans providing travel benefits might think twice about asking beneficiaries to document where their expenses were incurred. But the issue of preserving the privacy of personal health decisions goes far beyond the narrow question of disclosing abortion-related information. It goes to the entire reproductive life of every woman from menarche to menopause.
As a practicing physician in a community health center, I know that a woman’s pregnancy status is tightly intertwined with every aspect of her medical care, and not just the narrow issue of carrying a fetus to term. As healthcare providers, we routinely check a pregnancy test before prescribing contraceptive pills, implants, or injections or inserting an IUD. We check pregnancy status before prescribing many other medications or ordering X-rays that might harm a growing fetus. I may withhold medical clearance to undergo elective surgery until I have confirmed that an HCG test for pregnancy is negative. All these pregnancy test results are part of the patient’s permanent medical record.
When a woman of reproductive age seeks attention because of severe lower abdominal pain, we check a pregnancy test to exclude the possibility that she has an ectopic pregnancy, which is ordinarily a surgical emergency. When she experiences vaginal bleeding unrelated to her menstrual period, we check a pregnancy test to rule out an ongoing miscarriage. In a patient with a molar pregnancy, where some cells of the placenta grow into what is essentially a tumor and where the fetus is doomed, we monitor the HCG test every two weeks to make sure that the products of conception have been completely removed. When a woman has undergone an embryo implant as part of assisted reproduction, specialists monitor the HCG to see if the implant has taken. A determined state prosecutor will be able to use court-issued subpoenas and warrants to obtain all these test results.
In a separately issued post-Dobbs Guidance, OCR warned women that information on their smart phones may no longer be shielded from prosecutorial inquiry. If you have a menstrual period-tracking app on your phone that was not provided by your health plan, your data is unlikely to be covered by HIPAA’s privacy protections.
The End of Reproductive Privacy
In his majority opinion in Dobbs, Justice Alito ruled that Roe’s reliance on a broad constitutional right to privacy was misplaced. Instead, the majority scrapped the right to privacy in favor of an alternative notion of ordered liberty that balances the competing interests of a pregnant woman and the potential life of the unborn. Legal scholars can debate whether a constitutional right to privacy is recoverable from the debris of the wreckage. And legislators in both houses of Congress can work on bipartisan legislation to partially shore up federal privacy laws. But in states where abortion is criminalized, women of reproductive age and their healthcare providers will now have to make real-time decisions under the watchful prosecutorial eye of a new post-Roe panopticon.
Jeffrey E. Harris is a primary care physician with Eisner Health in Los Angeles, Calif., and professor of economics emeritus at the Massachusetts Institute of Technology in Cambridge, Mass. The views expressed here are the author’s and do not necessarily reflect the positions of Eisner Health, the Massachusetts Institute of Technology, or any other organization with which he is affiliated.
Suggested citation: Jeffrey E. Harris, The Demise of Roe Threatens the Privacy of a Woman’s Entire Reproductive Health Record, JURIST – Professional Commentary, August 9, 2022, https://www.jurist.org/commentary/2022/08/Jeffrey-Harris-Dobbs-abortion-reproductive-rights/.
Opinions expressed in JURIST Commentary are the sole responsibility of the author and do not necessarily reflect the views of JURIST's editors, staff, donors or the University of Pittsburgh.
The adoption of telecare using a variety of connected digital devices is opening the door to much more rapid response to medical emergencies, as well as more consistent monitoring, but it also is adding new challenges involving connectivity, security, and power consumption.
Telecare has been on the horizon for the better part of two decades, but it really began ramping with improvements in sensor technology and with the onset of the coronavirus pandemic. Rather than sitting in a waiting room or lingering in a hospital bed, sick patients now can talk to medical experts remotely using videoconferencing, and they can relay test results or developments digitally.
According to the U.S. Food and Drug Administration, many types of telecare services are available today to show test results and manage everything from skin conditions to prescriptions and urgent care issues. Devices track health goals, blood pressure, cholesterol, and even physical and occupational therapies. And all of that can happen remotely 24/7.
“Home health care is probably the number one use case for the smart home,” said Diya Soubra, director of segment strategy for Automotive and IoT at Arm. “The best scheme to handle the large population of elderly people is to allow them to age gracefully with dignity in their own homes. Remote health care is only economically possible with smart home devices. Smart and connected devices can act collectively to serve an elderly person by anticipating their needs. A collective that is AI-enabled thus removes the need for a tech-savvy consumer. We are at the starting point of such home-based health services, and the launch of the Matter protocol will accelerate deployment.”
As with any nascent technologies, there also are challenges. Medical device failures (both external and implanted) are common. So are connectivity interruptions. Power is another issue, particularly when a device’s functionality is dependent on a battery, and any loss of power or degradation of a connection can affect the quality of data being exchanged.
“Power will depend on the use,” said Kathy Tufto, senior product manager in Siemens EDA’s Embedded Software Division. “If the device is something like a wearable, then minimum power usage is important. Other considerations, such as low power, robustness, reliability, and ease-of-use are all important for in-home use. Since the person using the device is not trained — or has, at best, minimal training specific to the device — it needs to be robust, reliable, and easy to use. We’re also seeing more potential medical applications from devices that are not specifically medical, but are instead applications on a smart phone or watch. These have the same requirements, but since the device itself is not a medical device they will split along two lines — those that are part of therapy/maintenance with a medical professional involved, and those that are more simply informational for the end user, which is much of what we see today. I see these two sides coming together. As these capabilities become sufficiently reliable, they will be combined with other data that will be available to a person’s doctors for monitoring and diagnostic purposes.”
Security remains one of the big challenges for telecare, and one that needs to be addressed on an ongoing basis. Not all of these devices are secure initially, and not all of them will remain secure throughout their lifetimes. This is particularly daunting because the amount of data available through breaches, and the value of that data, is growing.
Cyberattacks on hospitals and care facilities are now regular occurrences. As the number of connected health care devices increases, so does the risk of cyberattacks. Alongside of that, debate continues about who owns the data collected from these connected medical devices. Where will the data be stored, and for how long? And if a ransomware attack occurs, who will be responsible for the damage caused by exposing patient health data?
Following recent breaches, patients were notified that security weaknesses would be addressed and they were offered free credit monitoring. But the bigger problem is the potential damage to a patient’s reputation and livelihood, and so far it’s not clear who is responsible if that happens.
“The hacking of medical devices has serious consequences,” said Steve Hanna, distinguished engineer at Infineon Technologies. “Not only will it compromise the privacy of the patients, such as exposing electronic health records, but it can also threaten the well-being of the patients. What is worse, ransomware attacks have grown to the point of affecting multiple parties. For example, hackers could demand the hospital pay a ransom. If refused, hackers could go to the patients and demand a ransom by threatening to sell patients’ personal health information underground. It is important to safeguard medical devices with a combination of things, including using secure hardware (security chips to perform authentication, encryption of sensitive data, and the management of cryptographic keys). Using software to detect the presence of malware is also important. Starting the design with secured chips is the important first step.”
Much more needs to be done, including setting standards for security and privacy. In addition, devices need to be updated to remain in compliance with those standards and to prevent new attacks, which in turn opens another possible avenue for attacks.
“It is expected that most edge devices, including connected medical devices, will be self-contained,” said Gijs Willemse, senior director of product management at Rambus. “Nevertheless, they are vulnerable due to their interfaces and the ability to receive software updates. Secure boot, device authentication, and secure communication, along with protection of provisioned key material, are critical for devices that operate in the public domain and/or could be confiscated. This requires a hardware root of trust, and depending on the performance and latency requirements of the application, hardware acceleration to encrypt/decrypt the data transferred over its interfaces. These hardware security cores should include anti-tamper protections to guard against side-channel and fault injection attacks.”
Navigating through a trove of constantly changing standards is a challenge by itself.
“There appear to be two different paths for home medical devices that rely on electronics/ software for their capabilities,” said Siemens’ Tufto. “For one class of devices, the same standards and guidance that apply to devices in a provider’s network will apply (such as IEC 62304 and ISO 13485). The other class of devices will not be medical-specific, but apps running on a multi-purpose device. If these applications are used as input to a person’s therapy, the same correctness and security considerations will still apply, since laws like HIPAA will also apply. For security, UL2900 has emerged, and many medical device manufacturers are implementing a security architecture that complies with this standard. The FDA has defined a concept called SaMD (Software as a Medical Device) and has published initial guidance on how these applications should be developed and how to identify and manage risk. This guidance will continue to grow with the industry.”
While the concept of remote, connected health care has been talked about for years, telecare is relatively new. Yet based on market growth predictions, it’s catching on quickly. Verified Market Research projects the global connected medical devices market size, including heart rate monitors, insulin pumps, and remote monitoring services would reach $137 billion by 2028, up from $27 billion in 2020.
Some of this is simple economics. On average in the United States, it cost $2,607 per day to stay in the hospital. For California and Oregon patients, that cost was $3,726 and $3,271, respectively. For both the health care provider and patient, there are strong financial incentives to discharge patients as soon as is practical. However, they still need to monitored for complications, and telehealth can provide 24/7 remote patient monitoring that until recently took place only within health care facilities.
Using telephone, video, and connected wearable medical devices which monitor patients’ vital signs, health data are received and analyzed either manually or going through M2M/IoT, ultimately saving both time and energy for the patients and caregivers. But this is easier said than done. It takes time to set up a telehealth technology infrastructure, which includes ongoing IT and network maintenance costs. Moreover, caregivers who may not have a technical background need training on how to operate telecare equipment, and patients need to learn how to use the online portal and apps. The massive amount of health data received requires processing, adding another burden.
Many different types of connected wearable medical devices/sensors are needed in remote patient monitoring, such as ECG or EKG monitors, temperature monitors, BP cuffs, and oxygen saturation (SpO2) monitors. There also are an increasing number of AI-based devices, such as Eko’s smart stethoscopes, which use algorithms to detect heart murmurs and atrial fibrillation. In conjunction with the Mayo Clinic, Eko is working on new research for a low ejection fraction algorithm known as ECG Low Ejection Fraction Tool (ELEFT) capable of detecting a weakened heart pump, which is present in about half of heart failure patients and could indicate that a heart attack will occur.
Fig. 1: AI-based stethoscopes use algorithms that can detect heart murmurs and atrial fibrillation (AFib) with performance comparable to human experts. Source: Eko
Remote patient monitoring (RPM) technology is improving. According to a survey conducted by Vivalink, the newer mobile cardiac telemetry (MCT) method is preferred by caretakers over the traditional Holter monitoring. Additionally, many new RPM applications are expected to use MCT.
The traditional Holter monitor is a small medical device worn by a patient with heart conditions for 24 to 48 hours. The built-in digital recorder, with five to seven electrodes connected to the patient, will record the electrocardiogram or ECG signals generated from the heart.
Fig. 2: Mobile cardiac telemetry (MCT) method used in RPM applications. Source: Vivalink
To simplify RPM design, biosensor chip manufacturers, including analog devices and ams-OSRAM AG are coming out with chips with an analog front-end (AFE) to support multiple functions such as ECG, SpO2, photoplethysmogram (PPG), and bioimpedance (BioZ), which are capable of measuring common vital signs including heart rate, respiration rate, blood pressure, oxygen saturation level, and even heart rate variability (HRV). HRV aka R-R interval measures the time between each heartbeat. Some of these chips consume very low power, ranging from microamps to milliamps, depending on the types of measurements, with supply voltage of less than 2 volts. Additionally, some of these functions can be turned off when not in use to further save power. Die sizes can be as small as 1.7mm<sup>2</sup>, which are needed for wearable devices like earbuds, smart patches, fitness bands, smart watches, and cuff-less optical blood pressure measurements.
For low-power AI applications, Synaptics developed a chip integrating an MCU with multiple sensors. The chip includes capacitive, inductive, Hall effect, and temperature sensing. Supporting functions like touch + force + proximity + temperature detection, the chip consumes only 240 µW in typical operation mode and 10 µW in sleep mode.
One of the big changes in this sector involves the addition of AI/ML.
“Based on the medical data gathered by medical devices, an AI system would be able to deduce the recommended actions or guide a user toward next steps in most scenarios,” said Boris Cipot, senior security engineer in Synopsys’ Software Integrity Group. “A smart set of home medical devices could help on the initial level to ensure that doctors are contacted only in conditions that are time-sensitive or require deeper or human analysis. Various sensors in AI-driven medical devices would associate certain symptoms to those stored in a database, enabling the technology to deduce if the patient is in urgent need of medical attention.”
AI also opens the door to entirely new business models associated with health care.
“AI technology adoption is happening in the medical device industry, and it’s not just driving exciting new features and high-end functionalities into the devices themselves,” said Dana McCarty, vice president of sales and marketing at Flex Logix. “This technology is also enabling manufacturers to reap the rewards from new service models, where instead of just selling and supporting devices, manufacturers can capture recurring service revenue streams, while at the same time strengthening customer relationships.”
This has a direct bearing on what kind of hardware is used inside of these devices, as well. “When choosing an AI accelerator, whether it is IP or chips, there are many factors to consider, including throughput, performance, processing at the edge, flexibility to update models, and power,” McCarty said.
All things considered, the future of telecare is bright, but the challenges ahead are also very real. With new investment coming to the health care industry, telecare will continue to grow and change. This in turn will energize new innovations in medical devices, sensors, networks, security, AI, and more.
Clothing with built-in smart sensors, for example, is a segment with great growth potential. The challenge is finding affordable textile materials and ways to ensure that electronic sensors are hermetically sealed and washable. Another area of interest is energy harvesting in wearable patient monitoring or implant devices. If energy can be captured from a person’s body heat or motion and applied to the wearable devices, it will lengthen the battery life.
But challenges will continue around patient privacy, securing medical devices and their connections, lowering the costs of operations, and creating devices that consumers will find easy to use. On top of that, insurance companies will need to support telehealth.
And finally, there are unanswered questions about what to do with the massive data generated from the connected medical devices. Should the data be stored, and by whom and for how long?
This market will continue to grow, but challenges will continue alongside of that growth.
CRN® Honoring Jason Magee of ConnectWise in 2022 Top 100 Executives List in the Disruptors Category (GlobeNewswire News Room) Magee Makes Second Consecutive Appearance on List...
Thoma Bravo doubles down on identity; backer of Inspire Fitness and Spotter raises debut fund (PE Hub) Thoma Bravo agrees to take Ping Identity private for $2.8 billion.
CMA provisionally clears NortonLifeLock / Avast merger (GOV.UK) The CMA has provisionally cleared the anticipated acquisition of Avast by NortonLifeLock following an in-depth merger investigation.
With Google’s Mandiant deal pending, Microsoft looks to get ahead in security threat intelligence (GeekWire) Microsoft announced two new security threat intelligence products Tuesday morning, the latest moves in a broader effort to help businesses proactively sniff out and prevent cyberattacks. Built in part on… Read More
Check Point Q2 profit gains on 'healthy' cyber security demand (Reuters) Check Point Software Technologies beat estimates with a 2% gain in second-quarter profit, boosted by double-digit growth in revenue from products and subscriptions to protect cloud and other networks from escalating cyber attacks.
Singtel ups investment in corporate venture arm Innov8 to US$350m (Business Times) SINGTEL has announced that it will increase its capital commitment for corporate venture capital (CVC) arm Singtel Innov8 from US$250 million to US$350 million.
OSINT Foundation Launched by Former Intelligence Leaders (ClearanceJobs) Today is the official launch of the newly formed Open Source Intelligence (OSINT) Foundation.
How Cyber Chiefs Cut Through Marketing Noise (Wall Street Journal) Here are five strategies corporate security chiefs use to weed out unsuitable cyber providers.
Gartner Magic Quadrant PAM | Delinea Positioned as a Leader (Delinea) Download a complimentary copy of Gartner’s 2020 report on the PAM market and vendors to see why Delinea is recognized as a leader.
Cybersecurity Growth Investment Flat, M&A Activity Strong for 2022 (SecurityWeek) While global markets have suffered, sales of cybersecurity software have remained strong. VC investment in cybersecurity has adapted to the world economy rather than stalled.
Cyber Insurance Price Hike Hits Local Governments Hard (Pew Trusts) Some rates have more than doubled, and many insurers require new security protections.
Cyber insurance is on the rise, and organizational security postures must follow suit (VentureBeat) When it comes to cyber insurance, much like other types of insurance, organizations should know what to look for — as well as what is expected of them.
Cybersecurity Snapshot (May 2022) (Momentum Cybersecurity) We are pleased to provide you with Momentum’s Cybersecurity Market Review for 1H 2022. Strategic activity in the first half of the year included 679 transactions completed totaling $115.1B in deal value across M&A (148 transactions, $102.6B) and Financing (531 transactions, $12.5B).
Intechnica announces separation of cybersecurity business (Business Up North) Intechnica – the Manchester-based tech company – has spun off its cybersecurity arm Netacea as a standalone company.
NCSC launches startup incubator to protect against national cyber threats (IT PRO) The program is focused on the protection of highly available operational technology where there is a high risk of digital sabotage
Harness Security Testing Orchestration Module is Now Generally Available to Accelerate Secure Software Delivery (Harness.io) We’ve incorporated valuable end user feedback into several key new features, which we are now excited to announce with the General Availability (GA) of the Harness Security Testing Orchestration module.
Crowdstrike's threat hunting cloud tool launched (SC Magazine) Crowdstrike unveiled a new cloud-based threat hunting service named Falcon OverWatch Cloud Threat Hunting, SiliconANGLE reports. According to the company, Falcon OverWatch is designed to detect hidden, advanced threats that originate, persist or are operating in cloud environments, provides constant operations and support to avert breaches and other incidents and provides attack alerts as well as adversary tradecraft to disrupt these threats.
Claroty Unveils Cybersecurity Platform for Cyber and Operational Resilience (Claroty) New Claroty xDome empowers enterprises to both modernize and protect the continuity of the cyber-physical systems that sustain our lives
Raytheon Intelligence & Space Selects CrowdStrike to Offer Cybersecurity Customers Best-in-Class Endpoint Security (Raytheon Intelligence & Space) Raytheon Intelligence & Space, a Raytheon Technologies business, has entered into a partnership with CrowdStrike, a leader in cloud-delivered protection of endpoints, cloud workloads, identity and data, to integrate its complementary endpoint security products into RI&S’ Managed Detection and Response (MDR) service.
Pentagon’s secret communications network to get upgrade from Booz Allen (Defense News) “DISA has made clear that we will not forget that the ‘fight’ is fought on SIPRNet,” said Christopher Barnhurst, the agency’s deputy director.
Axis Raises the Bar with Modern Day ZTNA Service that Boasts Hyper-Intelligence, Simplicity, and 350 Global Edges (Axis Security) Axis Security, the leader in zero trust access, today announced their VPN Buyback Program which provides IT leaders with a simple, cost-effective way of replacing their existing VPN service in order to adopt zero trust network access (ZTNA).
Ex-footballer Strengthens Defensive Wall in Cybersecurity (SureCloud) SureCloud partners with Phoenix, Sport & Media (PSM) Group to help train professional sports players in cybersecurity.
CREST Defensible Penetration Test Released (PR Newswire) CREST, the international not-for-profit, membership body representing the global cyber security industry, has announced the release of its...
02.08.2022: DerScanner receives the CWE Compatibility MITRE certificate (DerScanner) DerScanner, an application code scanner, developed by DerSecur, has received the CWE Compatibility certificate from MITRE, an American non-profit organization. This certificate confirms the effectiveness of DerScanner in solving the problem of detecting vulnerabilities, classified by the CWE system, in the software code.
EnCompass Achieves Blue Diamond Partner Status with Datto, a Kaseya Company (EnCompass Iowa) The Midwest’s leading IT service provider scales and grows as it equips SMBs with top-of-the-line security and IT solutions CEDAR RAPIDS, Iowa, August 1, 2022 -- EnCompass, a trusted computer and IT support vendor for small and medium-sized businesses (SMBs)...
Established Cybersecurity Firm, TDI, Now Offers Managed Cybersecurity Performance Offering with Award-Winning Platform (TDI) At the recent World Credit Union Conference (WCUC) in Glasgow, Scotland, TDI unveiled their Managed Cybersecurity Performance (MCP) offering, its pinnacle body of work, summing up over two decades of delivering cybersecurity solutions across the globe.
New infosec products of the week: July 29, 2022 (Help Net Security) The featured infosec products this week are from:
Kaspersky, Saudi Technology Control to combat cyberattack (Arab News) Global cybersecurity firm Kaspersky has signed a strategic agreement with Technology Control Company, a security services, digital services and big data company in Saudi Arabia, at the @Hack Infosec Conference 2021. The managed security service provider agreement was marked at the conference, one of Saudi Arabia’s most anticipated information-security events of the year. The move is in line with Technology Control Company’s commitment to providing its customers in Saudi Arabia with enhanced managed security services.
Everything Blockchain Inc. Launches EB Control (Business Wire) Everything Blockchain Inc., (OTCMKTS: OBTX), a technology company that enables real-world use of blockchain to solve critical business issues, today a
Fastly Partners with HUMAN Security to Protect Customers from Bot Attacks and Fraud (Business Wire) Fastly Partners with HUMAN Security to Protect Customers from Bot Attacks and Fraud
Booz Allen partners with Acalvio on cyber deception (Consulting) Booz Allen Hamilton, a McLean VA-based management and technology consulting firm, has partnered with Acalvio to provide the Silicon Valley cybersecurity firm’s Shadowplex autonomous deception product
Digitate’s Intelligent AIOps Platform Achieves HIPAA and GDPR Compliance (Yahoo Finance) Digitate, a leading provider of SaaS-based autonomous enterprise software for IT and business operations, today announced that it has achieved both HIPAA and GDPR compliance, guaranteeing that its artificial intelligence for IT operations (AIOps) platform meets all regulatory standards for security, availability, processing integrity, confidentiality, and privacy. The audits for both HIPAA and GDPR compliance were conducted by Deloitte Haskins & Sells, LLP.
SafeGuard Cyber integrates with Okta and Azure AD to automate identity-based responses for enterprises (Help Net Security) SafeGuard Cyber launched automated response and multi-channel user onboarding with Microsoft Azure AD and Okta integrations for its platform.
Troy Leach joins Cloud Security Alliance as Chief Strategy Officer (Help Net Security) Troy Leach joins Cloud Security Alliance as Chief Strategy Officer, reporting to the offices of the CEO and President.
Sigma7 Appoints Jennifer Gold as Chief Technology Officer (Yahoo) Global specialty risk services company Sigma7 announced Jennifer Gold's appointment as Chief Technology Officer. Ms. Gold will oversee all elements of Sigma7's back office and client facing technologies and data strategies, assure Sigma7 maintains industry-leading cyber security, and inform the company's cyber risk advisory and technology acquisition strategies. The addition of Ms. Gold to the rapidly scaling company will support Sigma7's efforts to revolutionize the client experience and elevat
Egnyte Solidifies Investment in India with New Head of India (Egnyte) Egnyte, the most secure platform for content collaboration and governance, today announced the appointment of Sachin Shetty as the Head of India, effective immediately. Shetty will lead all operations in the region, where Egnyte has more than 100 employees in engineering, product, and marketing.
Anomali Appoints Cyber Security Expert Steve Benton as Vice President and General Manager to Expand Growth of Anomali Intelligence-Driven Solutions (Business Wire) Anomali, a leader in intelligence-driven extended detection and response (XDR) cybersecurity solutions, today announced that Steve Benton has been app
Versa Networks Appoints DACH Region VP to Meet Accelerating Demand for Versa SASE (Telecom Reseller) Former Managing Director EU Central at Verizon Business, Pantelis Astenburg, joins Versa Networks to head up sales and support enterprises in the DACH region
Welcoming Manoj Nair: Snyk’s New Chief Product Officer (Snyk) We're thrilled to welcome Manoj Nair joins Snyk today as our new Chief Product Officer. In this pivotal phase of Snyk’s growth, Manoj will lead our global product team, setting our comprehensive product roadmap and strategy in both the short and long-term.
NetRise Welcomes Former CEO of Cylance to Board of Directors (NetRise) NetRise Welcomes Stuart McClure to Board of Directors
ShiftLeft Appoints Prevention-First, Cybersecurity Visionary and Artificial Intelligence/Machine Learning Pioneer Stuart McClure as Chief Executive Officer (ShiftLeft) ShiftLeft, a disruptor and innovator in the world of DevSecOps and NextGen SAST and SCA, today named Stuart McClure as CEO.
Cohesity Appoints Sanjay Poonen as CEO and President (Business Wire) Cohesity, a leader in next-gen data management, today announced the appointment of Sanjay Poonen as CEO and President. He will also join the Cohesity
Query.AI Appoints Cybersecurity Industry Veteran Matt Eberhart as CEO (PR Newswire) Query.AI, the provider of the market's only security investigations control plane for modern enterprises, today announced it has named...
Meta Platforms announces COO Sheryl Sandberg's resignation (SeekingAlpha) Meta Platforms (META) announced that Sheryl Sandberg informed the company of her decision to resign from COO position, effective Aug.1, and will continue to serve on company board.She...
General Dynamics IT hires former assistant to DISA director (Washington Technology) The 35-year Army veteran retired from military service in the spring.
Alan Masarek joins Avaya as President and CEO (Help Net Security) Avaya Holdings appoints Alan Masarek as its President and CEO and as a member of Avaya’s Board of Directors, effective August 1, 2022.
Axonius Appoints Tom Kennedy as Vice President of Axonius Federal Systems (Axonius) Axonius today announced it has appointed Tom Kennedy as its Vice President of Axonius Federal Systems LLC, the company’s government-focused subsidiary.
HackerOne Scoops Up Aledade Legal Chief Ilona Cohen (Corporate Counsel) Cohen said she's been a fan of HackerOne since it launched #HackThePentagon in partnership with the Department of Defense in 2016. Now, she'll lead its legal and public policy efforts.
Deep Instinct hires Carl Froggett as CIO (Help Net Security) Deep Instinct announced the addition of Carl Froggett to its executive leadership team as Chief Information Officer.
Called "forever chemicals" because they fail to break down fully in the environment, perfluoroalkyl and polyfluoroalkyl substances, better known as PFAS, have been used since the 1950s to make consumer products nonstick, oil- and water-repellent, and resistant to temperature change.
This family of synthetic chemicals has been a course of public debate for years as scientists and environmental advocates uncover additional evidence that certain PFAS are harmful to human health at increasingly lower levels.
On Thursday, the prestigious National Academies of Sciences, Engineering, and Medicine strode into the fray with a 300-plus-page report providing detailed advice for clinicians on how to test, diagnose and treat the millions of Americans who may have been exposed to PFAS.
"The National Academies are asked to do studies that would be free of the effects of advocacy, special interests, and politics, and are looked at as a trusted neutral body," said Dr. Ned Calonge, an associate professor of epidemiology at the Colorado School of Public Health and chair of the committee that wrote the report.
The report sets "nanogram" levels of concern and encourages clinicians to conduct blood tests on patients who are worried about exposure or who are at high risk. (A nanogram is equivalent to one billionth of a gram.)
People in "vulnerable life stages" -- such as during fetal development in pregnancy, early childhood and old age -- are at high risk, the report said. So are firefighters, workers in fluorochemical manufacturing plants and those who live near commercial airports, military bases, landfills, incinerators, wastewater treatment plants and farms where contaminated sewage sludge is used.
"These chemicals are ubiquitous in the American environment. More than 2,800 communities in the US, including all 50 states and two territories, have documented PFAS contamination," said Calonge, who is also an associate professor of family medicine at the School of Medicine on Colorado University's Anschutz Medical Campus.
Part of the committee's fact-gathering process was listening to citizens at town halls across the country. Pennsylvanian Hope Grasse, who was diagnosed with stage 4 cancer at age 25 after growing up near a naval base, described how her doctors laughed when she mentioned chemical exposure.
"They made me feel small; they made me feel stupid and embarrassed even just asking the question," she said at an April 2021 town hall, which was quoted in the report. "Clearly, they didn't have any information about environmental components (of disease)."
Michigan resident Sandy Wynn-Stelt discovered a landfill had contaminated her home's drinking water, according to the report. Levels were 1,000 times above what the Environmental Protection Agency considered safe, she said. After paying for a blood test out of pocket, she and her doctor found early-stage thyroid cancer.
"This report is a positive step forward. It's saying very clearly that exposure in a certain range is cause for concern," said toxicologist Linda Birnbaum, former director of the US Health and Human Services National Toxicology Program and National Institute for Environmental Health Sciences.
"Findings by the National Academies not only impact how scientists and physicians look at a topic, but how regulators and Congress do as well," said Birnbaum, who was not involved in the report. "And I think that's very, very important."
Living near a major source of PFAS isn't the only way to be exposed. Carpets, couches, nonstick cookware, stain-resistant clothes, cell phones, cosmetics, the lining of fast-food wrappers -- the list of popular products that contain PFAS are too numerous to mention and nearly impossible to avoid.
In fact, PFAS chemicals have been detected in the blood of 98% of Americans, according to a 2019 report using data from the National Health and Nutrition Examination Survey.
In the environment, PFAS can contaminate drinking water in public drinking water systems and private wells. The chemicals can accumulate in the bodies of fish, shellfish, livestock, dairy and game animals that people eat, according to the report.
The chemicals remain in the body until "exposure ceases," and while blood levels may drop over time, levels of PFAS "continue to persist even after exposure ends," the report said.
That's because PFAS can be stored for years in different organs in the body, said academies committee member Jane Hoppin, an environmental epidemiologist and deputy director of the Center for Human Health and the Environment at North Carolina State University in Raleigh.
Why years? It's due to the "half-life" of various PFAS substances -- the time it takes for the chemical concentration in the body to be reduced by 50%, she said.
"Some of these chemicals have half-lives in the range of five years," Hoppin said. "Let's say you have 10 nanograms of PFAS in your body right now. Even with no additional exposure, five years from now you would still have 5 nanograms.
"Five years later, you would have 2.5 and then five years after that, you'd have one 1.25 nanograms," she continued. "It would be about 25 years before all the PFAS leave your body."
The committee found "sufficient" scientific evidence of an association between PFAS exposure and an increased risk of adult kidney cancer and abnormally high cholesterol levels, the report said. Cholesterol contributes to cardiovascular disease, "the leading cause of death globally, taking an estimated 17.9 million lives each year," according to the World Health Organization.
The committee found PFAS exposure was also sufficiently associated with decreased infant and fetal growth as well as decreased antibody response to vaccines in both adults and children.
"Decreased immune response at a time when we're trying to immunize the population against Covid-19 ... we felt these were unique characteristics worthy of attention," Calonge said.
A number of other conditions were "suggestive" of an association to PFAS exposure. The committee had "moderate" confidence there was an increased risk for breast cancer, testicular cancer, ulcerative colitis, thyroid disease or dysfunction and pregnancy-induced high blood pressure and preeclampsia in adults. Both adults and children could also have alterations in their liver enzymes after exposure.
Gaps in research for conditions also thought to be affected by PFAS -- asthma, bone density, additional hormonal disruptions and neurological and childhood developmental issues, to name a few -- made it difficult for the committee to come to any conclusions about definite health risks. Evidence in those areas was labeled as "inadequate or insufficient."
However, the committee ended its research in June 2021. "I'm sure there is more information out there that may have been published very recently," Hoppin said.
"We're not saying there isn't a health impact. We just didn't have enough data to make a decision," she added. "So I think one of the most important recommendations we made is that we should be looking at the literature every two years and updating the guidance."
The report recommended blood tests look for seven PFAS that the CDC currently monitors: MeFOSAA, PFHxS, PFOA, PFDA, PFUnDA, PFOS and PFNA.
Greater than 20 nanograms per milliliter: If the sum of PFAS found in blood serum or plasma is 20 nanograms per milliliter or higher, the patient is at the greatest risk of adverse health effects, the committee said. (Remember that a nanogram is equivalent to one billionth of a gram.)
Clinicians should "encourage reduction of PFAS exposure for these patients," look for signs of testicular cancer and ulcerative colitis and test thyroid and kidney function at all wellness visits, the report said.
In addition, doctors should prioritize screening for cholesterol, breast cancer and hypertension during pregnancy.
Between 2 and 20 nanograms per milliliter: If the sum of the seven PFAS is between 2 and 20 nanograms per milliliter, there is a concern for adverse effects. Patients should reduce PFAS exposure and be screened for high cholesterol, breast cancer and hypertension during pregnancy.
Below 2 nanograms per milliliter: If blood concentration levels fall below 2 nanograms per milliliter, people "are not expected to have adverse health effects," the committee said.
However, those levels are already out of date, Birnbaum said. In June, the EPA put out interim hazard advisories that lower the levels of PFAS allowed in drinking water "so low you basically can't even measure them."
"It's what I would say was a 'shot across the bow,' basically telling municipalities, 'Guys, there's really no safe level of this stuff,' " Birnbaum said.
Just how do allowable levels in drinking water compare to recommended blood serum levels? They compare because the EPA "used human studies to derive safe exposure levels, or reference doses, that were then used to calculate a drinking water advisory," said David Andrews, a senior scientist for the Environmental Working Group, a consumer organization that monitors exposure to PFAS and other chemicals.
"EPA used a blood serum level of 0.17 ng/ml," Andrews said via email. "This serum level was significantly below 2 ng/ml and then EPA applied an additional 10x safety factor to make sure variations in response between different populations were also protected."
There are ways to lower exposure to PFAS chemicals, the report said. A key method is by filtering tap water, and the report points to a database of water filters that can reduce PFAS.
"The water filters that are most effective for PFAS are reverse osmosis filters, which are more expensive," Andrews said, adding that some carbon-based filters can reduce some levels as well.
"The important part is that you have to keep changing those filters," he said. "If you don't change that filter, and it becomes saturated, the levels of PFAS in the filtered water can actually be above the levels in the tap water."
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
LA JOLLA, Calif., July 28, 2022--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, has appointed two new members to its senior leadership team. Jennifer Eilemberg has been named chief compliance officer and will oversee the Company’s compliance with laws, regulatory requirements, rigorous internal policies and procedures. Steven Stone has stepped into the position of senior vice president of research and development and will guide the advancement of DermTech’s non-invasive skin genomics platform and diverse product pipeline.
"We are building an outstanding team of accomplished life science and healthcare leaders to steer the company as we look ahead to important operating milestones," said John Dobak, M.D., CEO, DermTech. "Jennifer and Steve both have excellent track records in their respective professions and we’re thrilled to have them on our team."
Ms. Eilemberg is an accomplished healthcare law executive with more than 20 years serving in positions of increasing responsibility in transactional and regulatory healthcare, and corporate matters. She has extensive experience in Laboratory Healthcare, U.S. Food and Drug Administration (FDA), Federal Stark and Anti-Kickback Law compliance, HIPAA/HITECH compliance, Medicare/Medicaid reimbursement and enrollment, state health care/professional regulatory compliance, payor/PBM contracting, mergers and acquisitions and a wide range of commercial transactions. She has provided counsel and legal representation before regulatory bodies including the Department of Justice, HHS Office of Inspector General, HHS Office for Civil Rights, Board of Medicine and Board of Pharmacy (multistate), Federal Trade Commission, FDA and Drug Enforcement Administration. She has also served as general counsel and chief compliance officer for several healthcare companies. Ms. Eilemberg is a member of the American Health Lawyers Association and a member of the New Jersey, Pennsylvania, and Florida Bars as well as Registered In-House Counsel in California.
Dr. Stone is a seasoned life sciences executive with significant experience developing molecular diagnostics. He was previously the vice president of Kidney Care at CareDx, leading a team that oversaw the research and development of several kidney care test offerings. Over 25 years, Dr. Stone served in positions of increasing responsibility at Myriad Genetics including as vice president of Cancer Genomics, where his group was responsible for the development of a molecular prognostic test for newly diagnosed prostate cancer (Prolaris). At Myriad, he was involved in the discovery and characterization of several important cancer genes including BRCA1 and p16. Dr. Stone received his Ph.D. in Genetics from the University of Minnesota. He has authored over 45 peer-reviewed publications and 10 U.S. patents.
DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech’s mission is to Excellerate the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using its Smart StickersTM. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information, please visit DermTech.
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of DermTech may differ from its genuine results and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, expectations and evaluations with respect to: the performance, patient benefits, cost-effectiveness, commercialization and adoption of DermTech’s products and the market opportunity for these products, DermTech’s positioning and potential revenue growth, financial outlook and future financial performance, operating milestones, implications and interpretations of any study results, the evaluation and judgments of the skills and experiences of the new members of DermTech’s senior leadership team, and expectations with respect to their future contributions to DermTech, and DermTech’s ability to expand its product offerings and develop pipeline products. These forward-looking statements involve significant risks and uncertainties that could cause the genuine results to differ materially from the expected results. Most of these factors are outside of the control of DermTech and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the outcome of any legal proceedings that may be instituted against DermTech; (2) DermTech’s ability to obtain additional funding to develop and market its products; (3) the existence of favorable or unfavorable clinical guidelines for DermTech’s tests; (4) the reimbursement of DermTech’s tests by Medicare and private payors; (5) the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for DermTech’s products; (6) DermTech’s ability to grow, manage growth and retain its key employees; (7) changes in applicable laws or regulations; (8) the market adoption and demand for DermTech’s products and services together with the possibility that DermTech may be adversely affected by other economic, business, and/or competitive factors; and (9) other risks and uncertainties included in the "Risk Factors" section of the most recent Annual Report on Form 10-K filed by DermTech with the Securities and Exchange Commission (the "SEC"), and other documents filed or to be filed by DermTech with the SEC, including subsequently filed reports. DermTech cautions that the foregoing list of factors is not exclusive. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. DermTech does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005047/en/
Exam Simulator 3.0.9 uses the actual HIPAA HIO-201 questions and answers that make up PDF Dumps. HIO-201 Exam Simulator is full screen windows application that provide you the experience of same test environment as you experience in test center.
We are a group of Certified Professionals, working hard to provide up to date and 100% valid test questions and answers.
We help people to pass their complicated and difficult HIPAA HIO-201 exams with short cut HIPAA HIO-201 PDF dumps that we collect from professional team of Killexams.com
We provide actual HIPAA HIO-201 questions and answers in PDF dumps that we obtain from killexams.com. These PDF dumps contains up to date HIPAA HIO-201 questions and answers that help to pass exam at first attempt. Killexams.com develop Exam Simulator for realistic exam experience. Exam simulator helps to memorize and practice questions and answers. We take premium exams from Killexams.com
PDF Dumps that we provide is updated on regular basis. All the Questions and Answers are verified and corrected by certified professionals. Online test help is provided 24x7 by our certified professionals. Our source of exam questions is killexams.com which is best certification exam dumps provider in the market.
We provide Live Chat and Email Support 24x7. Our certification team is available only on email. Order and Troubleshooting support is available 24x7.
4127 California St,
San Francisco, CA 22401
+1 218 180 22490